Early Experience with Human Papillomavirus Vaccine Introduction in the United States, Canada and Australia

被引:43
|
作者
Shefer, Abigail [1 ]
Markowitz, Lauri [2 ]
Deeks, Shelley [3 ]
Tam, Theresa [4 ]
Irwin, Kathleen [5 ]
Garland, Suzanne M. [6 ]
Schuchat, Anne [1 ]
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA
[2] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA
[3] Publ Hlth Agcy Canada, Ctr Infect Dis Prevent & Control, Immunisat & Resp Div, Ottawa, ON, Canada
[4] Publ Hlth Agcy Canada, Ctr Infect Dis Prevent & Control, Immunizat & Resp Infect Div, Ottawa, ON, Canada
[5] WHO, Initiat Vaccine Res, CH-1211 Geneva, Switzerland
[6] Univ Melbourne, Dept Obstet & Gynaecol, Royal Hosp Women, Dept Microbiol & Infect Dis, Melbourne, Vic, Australia
关键词
Human Papillomavirus; Vaccine; Vaccine schedule; Financing; Implementation;
D O I
10.1016/j.vaccine.2008.05.065
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Successful incorporation of a new vaccine into a nation's vaccination program requires addressing a number of issues, including: 1) establishing national recommendations; 2) assuring education of and acceptance by the public and medical community; 3) establishing and maintaining an appropriate infrastructure for vaccine delivery; 4) financing the vaccine and the program, in addition to political will. This article reviews the early experience with implementation of human papillomavirus (HPV) vaccination programs. It focuses on the United States of America and Canada and provides a brief report on Australia, where introduction is underway. Published by Elsevier Ltd.
引用
收藏
页码:K68 / K75
页数:8
相关论文
共 50 条
  • [41] Association of State Legislation of Human Papillomavirus Vaccination with Vaccine Uptake Among Adolescents in the United States
    Vielot, Nadja A.
    Butler, Anne M.
    Trogdon, Justin G.
    Ramadas, Ramya
    Smith, Jennifer S.
    Eyler, Amy
    JOURNAL OF COMMUNITY HEALTH, 2020, 45 (02) : 278 - 287
  • [42] An Update on Human Papillomavirus Vaccination in the United States
    Boitano, Teresa K. L.
    Ketch, Peter W.
    Scarinci, Isabel C.
    Huh, Warner K.
    OBSTETRICS AND GYNECOLOGY, 2023, 141 (02): : 324 - 330
  • [43] EXPERIENCE WITH MEASLES IN CANADA AND THE UNITED-STATES
    DAVIES, JW
    ACRES, SE
    VARUGHESE, PV
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1982, 126 (02) : 123 - 125
  • [44] Comparing human papillomavirus vaccine concerns on Twitter: a cross-sectional study of users in Australia, Canada and the UK
    Shapiro, Gilla K.
    Surian, Didi
    Dunn, Adam G.
    Perry, Ryan
    Kelaher, Margaret
    BMJ OPEN, 2017, 7 (10):
  • [45] Brief intelligence testing in Australia, Canada, the United Kingdom, and the United States
    Thompson, AP
    LoBello, SG
    Atkinson, L
    Chisholm, V
    Ryan, JJ
    PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE, 2004, 35 (03) : 286 - 290
  • [46] Decline in vaccine-type human papillomavirus prevalence in young men from a Midwest metropolitan area of the United States over the six years after vaccine introduction
    Widdice, Lea E.
    Bernstein, David, I
    Franco, Eduardo L.
    Ding, Lili
    Brown, Darron R.
    Ermel, Aaron C.
    Higgins, Lisa
    Kahn, Jessica A.
    VACCINE, 2019, 37 (45) : 6832 - 6841
  • [47] The Early Experience With Vedolizumab in the United States
    Kochar, Bharati
    Jiang, Yue
    Winn, Aaron
    Barnes, Edward L.
    Martin, Christopher F.
    Long, Millie D.
    Kappelman, Michael D.
    CROHNS & COLITIS 360, 2019, 1 (03)
  • [50] Human papillomavirus (HPV) knowledge, beliefs, and vaccine uptake among United States and international college students
    Karki, Ishu
    Dobbs, Page D.
    Larson, Daniel
    Maness, Sarah B.
    JOURNAL OF AMERICAN COLLEGE HEALTH, 2022, 70 (08) : 2483 - 2490